Chloe Cole Act
- Sponsor
- Rep. Onder, Robert F. [R-MO-3]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Sep 18, 2025
Bottom line
This bill seeks to federally ban gender-affirming care for minors and create broad legal avenues for individuals and parents to sue healthcare providers involved in such care, with significant implications for medical practice and patient rights.
What it actually does
This bill prohibits healthcare professionals, hospitals, and clinics from participating in "chemical or surgical mutilation" of individuals under 18, defined as interventions to halt natural development or change the body to no longer correspond to an individual's sex (e.g., puberty blockers, cross-sex hormones, certain surgeries). It establishes a federal private right of action for individuals or their parents to sue providers who performed such procedures, even retroactively, with strict liability for post-enactment acts.
Proponents argue
Supporters argue the bill protects children from irreversible medical procedures that they are too young to consent to, which they view as harmful and experimental. They contend that these interventions constitute "mutilation" of healthy bodies and that children should be allowed to reach adulthood before making such life-altering decisions. The private right of action is presented as a necessary mechanism for justice for those who regret their transitions.
Opponents contend
Opponents would argue that this bill interferes with established medical standards of care for gender dysphoria, denies necessary healthcare to transgender youth, and infringes on parental rights to make medical decisions for their children in consultation with healthcare providers. They would contend that gender-affirming care is evidence-based and life-saving for many, and that banning it could lead to increased mental health crises and suicide rates among transgender youth. The retroactive private right of action is likely to be criticized as an overreach and an attack on medical professionals.
The bill is relatively short and clearly written, making it accessible for an informed reader to understand its core provisions and implications within a reasonable timeframe.
Section 1
Short Title
This section establishes the official short title of the Act as the "Chloe Cole Act," making it easier to refer to the legislation. The name is intended to draw attention to the experiences of individuals who have detransitioned from gender-affirming care.
Supporters argue
Supporters would argue that naming the bill after Chloe Cole, an individual who detransitioned and advocates against gender-affirming care for minors, highlights the perceived harms the bill aims to prevent and gives a human face to the legislation's purpose.
Critics contend
Opponents might argue that using a specific individual's name in the title is a political tactic to emotionally sway public opinion rather than focusing on the policy merits, and that it sensationalizes a complex medical issue.
Tradeoffs
The use of a specific individual's name can personalize the issue, potentially garnering support from those who identify with the individual's story, but may also be seen as politicizing medical care.
Section 2
Definitions of Key Terms
This section defines critical terms used throughout the Act. "Chemical or surgical mutilation" is broadly defined to include puberty blockers, sex hormones, and surgeries intended to halt natural development or change an individual's body to no longer correspond to their sex, with specific exclusions for verifiable disorders of sexual development, treatment of complications, or acute illnesses. A "child" is defined as an individual under 18 years of age. "Sex" is defined as a person's immutable biological classification, determined at the moment of conception, as either male or female.
Section 3
Federal Prohibition on Gender-Affirming Care for Minors
This section prohibits health care professionals, hospitals, or clinics from participating in the "chemical or surgical mutilation" of a child (under 18) under various circumstances involving interstate commerce or federal jurisdiction. It also requires clear and convincing evidence to support any exception to this prohibition, placing a high evidentiary burden on providers.
Section 4
Private Right of Action for Damages
This section creates a civil cause of action allowing individuals who received prohibited "chemical or surgical mutilation" as a child, or their parents/guardians, to sue healthcare professionals, hospitals, or clinics involved. This right of action applies regardless of when the alleged mutilation occurred (before, on, or after enactment). It allows for compensatory, non-economic, and punitive damages. For acts occurring after enactment, strict liability applies, and the burden of proving an exception rests with the defendant by clear and convincing evidence.
Section 6
Extended Statute of Limitations
An action under the private right of action (Section 4) may be brought within 25 years from the individual's 18th birthday or within 4 years from when the cost of detransition treatment is incurred, whichever is later. This provides a very long window for potential lawsuits.
The term "participate" is broadly defined to include directly engaging in the planning, authorization, prescription, administration, or performance of any act constituting chemical or surgical mutilation. This encompasses prescribing, administering, performing surgeries, authorizing/directing as a supervisor, or knowingly planning/coordinating such treatments.
Section 2(6)
Why it matters:This is standard legislative practice to ensure comprehensive coverage of who is liable under the Act, but its broadness is consequential for the scope of potential defendants.
Case for: Proponents would argue that a broad definition of "participate" is necessary to ensure accountability for all individuals and entities involved in facilitating prohibited care, not just those directly performing procedures.
Case against: Opponents might argue that such a broad definition could ensnare individuals in administrative or supportive roles who are not directly involved in medical decision-making or treatment, creating an overly punitive environment for healthcare systems.
Estimated impact: Significantly expands the pool of potential defendants in lawsuits, increasing legal risk for a wider range of healthcare system personnel.
For acts of "chemical or surgical mutilation" occurring after the date of enactment, health care professionals, hospitals, or clinics are strictly liable for damages if their participation is proven by clear and convincing evidence. If an exception is raised as an affirmative defense, the defendant bears the burden of proving that exception by clear and convincing evidence.
Section 4(c)
Why it matters:This is standard legal drafting to specify evidentiary standards, but it has profound implications for defendants by altering traditional tort law principles in medical contexts.
Case for: Proponents would argue that strict liability and shifting the burden of proof to the defendant for exceptions are necessary to ensure justice for children, given the irreversible nature of the procedures and the power imbalance between patients and providers.
Case against: Opponents would argue that strict liability is an extreme standard for medical practice, potentially leading to unjust outcomes, and that shifting the burden of proof to the defendant for exceptions is an unfair legal hurdle for healthcare providers, making defense exceptionally difficult.
Estimated impact: Significantly lowers the bar for plaintiffs to win lawsuits for post-enactment actions, and makes it much harder for defendants to successfully argue exceptions, dramatically increasing legal risk for providers.
In cases where "chemical or surgical mutilation" occurred before the date of enactment of this Act, there is "limited deference to prevailing standards of care" if such standards contradict the Act's intent and the health care professional "knew or should have known that such standards of care were in serious, scientific, and medical dispute" at the time.
Section 5(4)
Why it matters:This is a complex legal carve-out that modifies how past medical practices will be judged, making it a critical detail for legal interpretation and for understanding the scope of retroactive liability.
Case for: Proponents would argue this provision is necessary to allow individuals harmed by past practices to seek justice, even if those practices were considered "standard of care" at the time, if there was a known scientific dispute. This aims to prevent providers from simply claiming they followed outdated or contested guidelines.
Case against: Opponents would argue that this provision creates an impossible standard for healthcare professionals, requiring them to foresee future legal interpretations and making them liable for practices that were widely accepted at the time. It undermines the principle of judging actions based on the knowledge and standards available at the time.
Estimated impact: Opens the door for retroactive lawsuits against providers who followed then-current standards of care, if those standards are later deemed to have been "in serious, scientific, and medical dispute," creating significant legal uncertainty for past medical acts.